Keyhole limpet haemocyanin (Intracel Corp)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameKeyhole limpet haemocyanin (Intracel Corp)
Drug Alias NameBCI-ImmuneActivatorKLH
ClassificationNatural product/ExtractBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDermatitis, AtopicUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntracel Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A